Bufei Huoxue capsule attenuates COPD-related inflammation and regulates intestinal microflora, metabolites

Bufei Huoxue capsule attenuates COPD-related inflammation and regulates intestinal microflora, metabolites

Background: Bufei Huoxue capsule (BFHX) is widely used for the clinical treatment of chronic obstructive pulmonary disease (COPD) in China.Objectives: The aim of this study is to explore the effects on COPD and the underlying mechanism of BFHX.The process and methods: In this study, we established a...

Full description

Bibliographic Details
Main Authors: Yuanyuan Li, Jiali Chen, Yue Xing, Jian Wang, Qiuling Liang, Jiamin Zeng, Siyi Wang, Qiong Yang, Jianing Lu, Jieying Hu, Wenju Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Pharmacology
Subjects:
Bufei Huoxue capsule
chronic obstructive pulmonary disease
inflammation
intestinal flora
metabolites
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1270661/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1270661/full

Similar Items